Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study
Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study(120 visite) Coppo C, Bonfanti D, Bo S, Giordanino C, Gallo M, Cococcia S, Ciccone G, Smedile A, Ciancio A, Bugianesi E, Fagoonee S, Pellicano R, Rizzetto M, Saracco GM
Parole chiave: Chronic Hepatitis C; Cirrhosis; Diabetes Mellitus; Macroangiopathy; Microangiopathy, Alpha Fetoprotein, Hepatitis B Surface Antigen, Insulin, Insulin Sensitizing Agent, Interferon, Oral Antidiabetic Agent, Ribavirin, Adult, Antiviral Therapy, Article, Autonomic Neuropathy, Body Mass, Cohort Analysis, Controlled Study, Coronary Artery Disease, Diabetic Foot, Diabetic Microangiopathy, Diabetic Nephropathy, Diabetic Neuropathy, Diabetic Patient, Diabetic Retinopathy, Disease Duration, Family History, Female, Follow Up, Heart Infarction, Hepatitis C Virus, Human, Human Tissue, Incidence, Insulin Treatment, Liver Cancer, Liver Cirrhosis, Liver Histology, Long Term Care, Major Clinical Study, Middle Aged, Non Insulin Dependent Diabetes Mellitus, Obesity, Outcome Assessment, Peripheral Occlusive Artery Disease, Priority Journal, Retrospective Study, Risk Assessment, Risk Factor, Smoking, Treatment Duration, Cardiovascular Diseases, Comorbidity, Complication, Type 2, Diabetic Angiopathies, Pathology, Cohort Studies, Retrospective Studies,
Affiliazioni:
*** IBB - CNR *** Gastroenterology Unit, Department of Oncology, University of Turin, Turin, Italy Department of Medical Sciences, University of Turin, Turin, Italy Unit of Cancer Epidemiology, University of Turin, Molinette Hospital and CPO Piemonte, Turin, Italy Gastro-Hepatology Unit, Department of Medical Sciences, University of Turin, Turin, Italy Institute for Biostructures and Bioimages (CNR), Molecular Biotechnology Center, University of Turin, Italy
Riferimenti:
Garcia-Compean, D., Jaquez-Quintana, J.O., Gonzalez-Gonzalez, J.A., Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management (2009) World Journal of Gastroenterology, 15, pp. 280-28
Holstein, A., Hinze, S., Thiessen, E., Clinical implications of hepatogenous diabetes in liver cirrhosis (2002) Journal of Gastroenterology and Hepatology, 17, pp. 677-681
Bianchi, G., Marchesini, G., Zoli, M., Prognostic significance of diabetes in patients with cirrhosis (1994) Hepatology, 20, pp. 119-125
Marchesini, G., Ronchi, M., Forlani, G., Cardiovascular disease in cirrhosis: a point-prevalence study in relation to glucose tolerance (1999) American Journal of Gastroenterology, 94, pp. 655-662
Kuriyama, S., Miwa, Y., Fukushima, H., Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease (2007) Journal of Clinical Biochemistry and Nutrition, 40, pp. 116-122
Mehta, S.H., Brancati, F.L., Sulkowski, M.S., Prevalence of type 2 diabetes mellitus among persons with hepatitis C infection in the United States (2000) Annals of Internal Medicine, 133, pp. 592-599
Petta, S., Macaluso, F.S., Craxì, A., Cardiovascular diseases and HCV infection: a simple association or more? (2014) Gut, 63, pp. 369-375
Knobler, H., Schimanter, R., Zifroni, A., Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection (2000) Mayo Clinic Proceedings, 75, pp. 355-359
Persico, M., Capasso, M., Persico, E., Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy (2007) Hepatology, 46, pp. 1009-1015
Hickman, I.J., Powell, E.E., Prins, J.B., In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implication for therapy (2003) Journal of Hepatology, 39, pp. 1042-1048
Ratziu, V., Munteanu, M., Charlotte, F., Fibrogenic impact of high serum glucose in chronic hepatitis C (2003) Journal of Hepatology, 39, pp. 1049-1055
Veldt, B.J., Chen, W., Heathcote, J., Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus (2008) Hepatology, 47, pp. 1856-1862
Hung, C.H., Lee, C.M., Wang, J.H., Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy (2011) International Journal of Cancer, 128, pp. 2344-2352
Giordanino, C., Ceretto, S., Bo, S., Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study (2012) Digestive and Liver Disease, 44, pp. 406-412
Chehadeh, W., Kurien, S.S., Abdella, N., Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications (2011) Journal of Infection and Public Health, 4, pp. 200-206
The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (1993) Archives of Internal Medicine, 153, pp. 154-183
Diagnosis and classification of diabetes mellitus (2005) Diabetes Care, 28, pp. S37-S42
Ishak, K., Baptista, A., Bianchi, L., Histological grading and staging of chronic hepatitis (1995) Journal of Hepatology, 22, pp. 696-699
Kettaneh, A., Marcellin, P., Douvin, C., Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients. A prospective study of 935 patients (2007) Journal of Hepatology, 46, pp. 628-634
El Serag, H.B., Everhart, J.E., Diabetes increases the risk of acute hepatic failure (2002) Gastroenterology, 122, pp. 1822-1828
Nishida, T., Tsuji, S., Tsuji, M., Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis (2006) American Journal of Gastroenterology, 101, pp. 70-75
Huang, Y.W., Yang, S.S., Fu, S.C., Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study (2014) Hepatology, 60, pp. 807-814
Elkrief, L., Chouinard, P., Bendersky, N., Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C (2014) Hepatology, 60, pp. 823-831
Fujiwara, F., Ishii, M., Taneichi, H., Low incidence of vascular complications in patients with diabetes mellitus associated with liver cirrhosis as compared with type 2 diabetes mellitus (2005) Tohoku Journal of Experimental Medicine, 205, pp. 327-334
Melato, M., Mucli, E., Poldrugo, F., Stroke-cirrhosis relationship: an autopsy study in a heavy drinking population (1991) Italian Journal of Gastroenterology, 23, pp. 211-214
Berzigotti, A., Bonfiglioli, A., Muscari, A., Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis (2005) Liver International, 25, pp. 331-336
D'Arienzo, A., Manguso, F., Scaglione, G., Prognostic value of progressive decrease in serum cholesterol in predicting survival in Child-Pugh C viral cirrhosis (1998) Scandinavian Journal of Gastroenterology, 33, pp. 1213-1218
Hsu, Y.C., Lin, J.T., Ho, H.J., Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients (2014) Hepatology, 59, pp. 1293-1302
<h4>BACKGROUND: </h4><br>Patients<br> with chronic hepatitis C have an increased risk of diabetes mellitus <br>but the type and risk of developing diabetes-related complications have <br>not yet been evaluated.<br><h4>METHODS: </h4><br>In<br> order to compare the incidence of diabetic microangiopathy in patients <br>with new onset diabetes without microangiopathy we recruited 54 <br>hepatitis C virus (HCV)-positive and 119 HCV-negative patients from <br>January 2005 to December 2006. All patients were followed-up every 6 <br>months for liver and diabetic complications and incidence of <br>cardiovascular diseases up to December 2012 when data were <br>retrospectively analyzed.<br><h4>RESULTS: </h4><br>The<br> two cohorts were comparable at enrolment except for mean body mass <br>index, obesity rate and family history of diabetes (p=0.007). After 7.2 <br>years of follow-up, 13 HCV-positive (24.1%) and 37 HCV-negative patients<br> (31%) showed at least one microangiopathic complication (p=0.34); 5 <br>HCV-positive (9.3%) and 13 HCV-negative patients (10.8%) reported <br>cardiovascular diseases (p=0.2); 14 HCV-positive (24.5%) compared to 0 <br>HCV-negative patients developed liver-related complications (p=0.0003). <br>One HCV-positive patient died due to liver cancer, 1 HCV-negative <br>patient died from myocardial infarction (p=0.3). Increasing age <br>(HR=1.04, 95% CI: 1.00-1.07, p=0.04) and smoking (HR=2.94, 95% CI: <br>1.06-8.17, p=0.04) were positively associated to diabetic complications.<br><h4>CONCLUSIONS: </h4><br>Incidence of microangiopathy is not significantly different in diabetics with or without chronic hepatitis C.<br>
79 Records (74 escludendo Abstract e Conferenze). Impact factor totale: 308.36 (290.025 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 307.728 (289.928 escludendo Abstract e Conferenze).
ibb.cnr.it